Lebrikizumab (Anti-IL-13)

Lebrikizumab (anti-IL-13) is an humanized IgG4 monoclonal antibody against interleukin 13 (IL-13) with immunosuppressive and anti-asthmatic activities. MW: 145.8 KD.

• Supplier: Selleck Chemicals
• Product #: A2954
• Sku #: A2954-1mg